Skip to main content

Table 1 Patients’ characteristics

From: Early assessment with 18F-2-fluoro-2-deoxyglucose positron emission tomography/computed tomography to predict short-term outcome in clear cell renal carcinoma treated with nivolumab

Pt Age Histological Type T stage Tumor Grade KPS Prior Therapy
1st 2nd 3rd 4th 5th 6th 7th
1 60s clear 3 G2 90 SU EVR AXT PAZ TEM   
2 70s clear 1a G1 100 INF SFN EVR AXT    
3 60s clear 2a G1 100 SU AXT EVR PAZ SFN   
4 60s clear 4 G1 100 SU AXT PAZ     
5 60s clear 1b G2 100 INF SFN EVR AXT SU TEM PAZ
6 60s clear 3a G2 100 INF SFN      
7 60s clear 1b G1 90 SFN EVR AXT     
8 60s clear 3a G2 100 SFN AXT EVR SU    
9 70s clear 1b G3 90 SFN EVR      
  1. KPS Karnofsky performance status, SU Sunitinib, SFN Sorafenib, EVR Everolimus, AXT Axitinib, PAZ Pazopanib, TEM Temsirolimus, INF Interferon-alpha